• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜伏型和活性纤溶酶原激活物抑制剂1(PAI-1)之间的构象差异:一项光谱学研究

Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: a spectroscopic study.

作者信息

Boström S, Deinum J, Löfroth J E, Wirth M, Kubista M

机构信息

Hässle Cardiovascular Research Laboratories, Mölndal, Sweden.

出版信息

Thromb Res. 1990 Sep 1;59(5):851-8. doi: 10.1016/0049-3848(90)90398-v.

DOI:10.1016/0049-3848(90)90398-v
PMID:2237839
Abstract

The protein conformation of latent and active PAI-1 has been studied with circular dichroism, absorbance and fluorescence spectroscopy. The far ultraviolet circular dichroism spectrum of latent PAI-1 displays a more negative band at 220 nm than active PAI-1, crossing the baseline at a lower wavelength. Active PAI-1 shows an absorption maximum at lower wavelength (269 nm) than present in latent PAI-1 (278 nm). In consistency, slow denaturation of active PAI-1 by incubation for two hours at 37 degrees C induces a shift in the absorption maximum from 268 nm to 274 nm. The fluorescence emission maximum of latent PAI-1 is at lower wavelength (335 nm) than that of active PAI-1 (340 nm). These spectroscopic differences are interpreted as reflecting a more tight conformation, with the tryptophan residues in a more apolar environment, in latent PAI-1 compared to active PAI-1.

摘要

已通过圆二色性、吸光度和荧光光谱法研究了潜伏型和活性型纤溶酶原激活物抑制剂-1(PAI-1)的蛋白质构象。潜伏型PAI-1的远紫外圆二色光谱在220nm处显示出比活性型PAI-1更负的谱带,在更低波长处穿过基线。活性型PAI-1在比潜伏型PAI-1(278nm)更低的波长(269nm)处显示出最大吸收。与此一致的是,活性型PAI-1在37℃孵育两小时进行缓慢变性会导致最大吸收波长从268nm移至274nm。潜伏型PAI-1的荧光发射最大值在比活性型PAI-1(340nm)更低的波长(335nm)处。这些光谱差异被解释为反映了与活性型PAI-1相比,潜伏型PAI-1具有更紧密的构象,色氨酸残基处于更非极性的环境中。

相似文献

1
Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: a spectroscopic study.潜伏型和活性纤溶酶原激活物抑制剂1(PAI-1)之间的构象差异:一项光谱学研究
Thromb Res. 1990 Sep 1;59(5):851-8. doi: 10.1016/0049-3848(90)90398-v.
2
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).重组纤溶酶原激活物抑制剂-1(rPAI-1)中的动态结构与功能关系
Biochim Biophys Acta. 1993 Oct 6;1202(2):221-9. doi: 10.1016/0167-4838(93)90008-f.
3
A spectroscopic study of the conformations of active and latent forms of recombinant plasminogen activator inhibitor-1.重组纤溶酶原激活物抑制剂-1活性和潜伏形式构象的光谱研究
Biochem Biophys Res Commun. 1991 Mar 15;175(2):437-43. doi: 10.1016/0006-291x(91)91583-x.
4
Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.对活性、潜伏、底物和裂解形式的纤溶酶原激活物抑制剂(PAI-1)的构象研究。
Biochemistry. 1995 Jan 24;34(3):1064-9. doi: 10.1021/bi00003a042.
5
Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.
J Biol Chem. 1992 Jun 15;267(17):11693-6.
6
Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂1的动力学控制折叠
Biochemistry. 1996 Dec 24;35(51):16443-8. doi: 10.1021/bi961214p.
7
A spectroscopic study of the structures of latent, active and reactive-center-cleaved type-1 plasminogen-activator inhibitor.1型纤溶酶原激活物抑制剂的潜伏型、活性型及反应中心裂解型结构的光谱研究
Eur J Biochem. 1996 Sep 15;240(3):550-5. doi: 10.1111/j.1432-1033.1996.0550h.x.
8
Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.
Blood. 1987 Oct;70(4):1090-8.
9
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.纤溶酶原激活物抑制剂-1处于活性构象并在结合配体时聚合,从而中和其活性。
Int J Mol Med. 2006 Mar;17(3):437-47.
10
The oxidative inactivation of plasminogen activator inhibitor type 1 results from a conformational change in the molecule and does not require the involvement of the P1' methionine.
J Biol Chem. 1991 Jul 25;266(21):13852-8.